Matches in Wikidata for { <http://www.wikidata.org/entity/Q83656066> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q83656066 description "artículu científicu espublizáu en marzu de 2011" @default.
- Q83656066 description "im März 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83656066 description "scientific article published on 21 March 2011" @default.
- Q83656066 description "wetenschappelijk artikel" @default.
- Q83656066 description "наукова стаття, опублікована в березні 2011" @default.
- Q83656066 name "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination" @default.
- Q83656066 name "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination" @default.
- Q83656066 type Item @default.
- Q83656066 label "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination" @default.
- Q83656066 label "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination" @default.
- Q83656066 prefLabel "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination" @default.
- Q83656066 prefLabel "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination" @default.
- Q83656066 P1433 Q83656066-03F30CCE-2CF6-4850-8103-921C1EC49942 @default.
- Q83656066 P1476 Q83656066-24D6C88B-91FD-428F-9DA3-4CD5FBEEAD45 @default.
- Q83656066 P2093 Q83656066-869CE8A4-BC05-41FF-A0CF-5E526A30C4DB @default.
- Q83656066 P2093 Q83656066-CB8A3584-E04B-4209-A181-8E7D6DA87C2C @default.
- Q83656066 P2860 Q83656066-1417F9ED-95DB-488E-8A52-58C39112971C @default.
- Q83656066 P2860 Q83656066-2F2672C3-04B8-4BBD-B62A-0E34463E6205 @default.
- Q83656066 P2860 Q83656066-ED932C3E-17FA-42DA-8CDC-EC8620FAA507 @default.
- Q83656066 P2860 Q83656066-EEF1690C-4C9A-4492-ADF9-2A157F7D2ED4 @default.
- Q83656066 P304 Q83656066-0A8499B2-F64F-45ED-8DB8-42767CF5D1B5 @default.
- Q83656066 P31 Q83656066-BF5D1153-A497-4334-AD9A-7561D1323CFC @default.
- Q83656066 P356 Q83656066-5E4999A7-4F49-47FF-8E90-0F47310DC74F @default.
- Q83656066 P433 Q83656066-1423E0D8-3AE8-4FC9-A941-571D8C0D8876 @default.
- Q83656066 P478 Q83656066-20292160-33BA-4FEE-BCAA-646A5C5C0B28 @default.
- Q83656066 P577 Q83656066-136307CE-6CCD-47B0-9FF2-0872E810C807 @default.
- Q83656066 P698 Q83656066-2D191093-3E9C-48EE-B0CF-51EE59C92143 @default.
- Q83656066 P356 J.VACCINE.2011.03.007 @default.
- Q83656066 P698 21420415 @default.
- Q83656066 P1433 Q7907941 @default.
- Q83656066 P1476 "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination" @default.
- Q83656066 P2093 "Mads Hald Andersen" @default.
- Q83656066 P2093 "Per Thor Straten" @default.
- Q83656066 P2860 Q33501195 @default.
- Q83656066 P2860 Q35751070 @default.
- Q83656066 P2860 Q36809762 @default.
- Q83656066 P2860 Q83364948 @default.
- Q83656066 P304 "3728" @default.
- Q83656066 P31 Q13442814 @default.
- Q83656066 P356 "10.1016/J.VACCINE.2011.03.007" @default.
- Q83656066 P433 "21" @default.
- Q83656066 P478 "29" @default.
- Q83656066 P577 "2011-03-21T00:00:00Z" @default.
- Q83656066 P698 "21420415" @default.